Detalles de la búsqueda
1.
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer
; 23(1): 136, 2023 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765293
2.
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study.
Neoplasma
; 70(1): 158-165, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36620878
3.
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Anticancer Drugs
; 33(7): 663-670, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35703239
4.
Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue Sarcoma.
Clin Lab
; 68(2)2022 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142203
5.
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Eur J Cancer Care (Engl)
; 29(6): e13296, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32864838
6.
Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
J Cancer Educ
; 35(1): 69-75, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30446981
7.
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer
; 23(1): 192, 2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36849943
8.
Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study.
Cancer Invest
; 35(4): 248-255, 2017 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28333566
9.
Attitudes of cancer patients after diagnosis: How cancer affects social life? A Turkish Oncology Group study.
J BUON
; 22(1): 208-213, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28365956
10.
Ginseng and cancer.
J BUON
; 21(6): 1383-1387, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28039696
11.
Ganoderma Lucidum (Reishi Mushroom) and cancer.
J BUON
; 21(4): 792-798, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27685898
12.
Curcumin (Turmeric) and cancer.
J BUON
; 21(5): 1050-1060, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27837604
13.
Tendency of cancer patients and their relatives to use internet for health-related searches: Turkish Oncology Group (TOG) Study.
J BUON
; 21(3): 714-9, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27569068
14.
Do medical oncologists and cancer patients care about treatment costs of systemic anticancer therapy?
J BUON
; 20(6): 1606-11, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26854459
15.
Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study.
J BUON
; 20(4): 1137-41, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26416068
16.
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.
Cancer Med
; 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140782
17.
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.
J Cancer Res Ther
; 18(12 Suppl 2): S347-S353, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36510987
18.
Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study.
Arch Med Sci
; 17(4): 920-927, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34336021
19.
Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group.
J BUON
; 24(2): 650-655, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128019
20.
A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).
J BUON
; 24(1): 136-142, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941962